Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
posted on
Feb 20, 2022 12:36PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
narmac wrote - "That doesnt mean the science is fraudulant or other."
What I find truly exciting about RVX and ZEN is the fact that are successfuly achieving breakthrough revolutionary medical science not just witnessed by their own trial results but also prestigious scientific journals like Cell and others. In addition we have numerous independent academic scientists doing their own, independent experiements using apabetalone. zen3694 has attracted numerous partners in various cancers including Pfizer, NIH/NCI, Newsoara, etc. It will be fabulous when they finally achieve FDA approval for one of there moleclues. At that event scientifc credibility, investor excitement and BP will all be at the door and visibility in the media will be stratospheric.
For now we will suffer the huge management discount. It requires incredible patience.
GLTA
Toinv